Regen BioPharma Inc Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regen BioPharma Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
  • Regen BioPharma Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$108K, a 26.8% decline year-over-year.
  • Regen BioPharma Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$391K, a 46.1% increase year-over-year.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2023 was -$687K, a 102% decline from 2022.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2022 was -$340K, a 69.2% decline from 2021.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2021 was -$201K, a 4.08% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$391K -$108K -$22.8K -26.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$368K -$101K -$22.2K -28.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 -$346K -$123K +$341K +73.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-01-19
Q3 2023 -$687K -$59.1K +$38.7K +39.6% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-20
Q2 2023 -$726K -$85.2K -$26.2K -44.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$699K -$78.8K -$2.35K -3.07% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 -$697K -$464K -$357K -336% Oct 1, 2022 Dec 31, 2022 10-Q 2024-01-19
Q3 2022 -$340K -$97.8K +$29K +22.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-20
Q2 2022 -$369K -$58.9K -$16.4K -38.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 -$352K -$76.5K -$63.5K -490% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-18
Q4 2021 -$289K -$106K -$87.9K -476% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-19
Q3 2021 -$201K -$127K -$108K -571% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-15
Q2 2021 -$92.9K -$42.5K -$26.2K -160% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-22
Q1 2021 -$66.7K -$13K +$26.4K +67% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q4 2020 -$93.1K -$18.5K +$116K +86.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-20
Q3 2020 -$209K -$18.9K +$171K +90% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-22
Q2 2020 -$380K -$16.3K +$121K +88.1% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-22
Q1 2020 -$501K -$39.3K +$191K +83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-18
Q4 2019 -$693K -$135K +$64.1K +32.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-13
Q3 2019 -$757K -$189K -$216K -809% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-04
Q2 2019 -$541K -$138K -$12.5K -9.97% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-05
Q1 2019 -$528K -$231K +$217K +48.4% Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-05
Q4 2018 -$745K -$199K +$681K +77.4% Oct 1, 2018 Dec 31, 2018 10-Q 2021-08-05
Q3 2018 -$1.43M $26.7K +$792K Jul 1, 2018 Sep 30, 2018 10-K 2021-06-21
Q2 2018 -$2.22M -$125K +$428K +77.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-24
Q1 2018 -$2.65M -$448K +$211K +32.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-29
Q4 2017 -$2.86M -$880K -$346K -64.8% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
Q3 2017 -$2.51M -$765K -$88.2K -13% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-27
Q2 2017 -$2.42M -$553K +$318K +36.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$2.74M -$659K +$60.7K +8.44% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$2.8M -$534K +$156K +22.6% Oct 1, 2016 Dec 31, 2016 10-Q 2017-01-27
Q3 2016 -$2.96M -$677K -$154K -29.4% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-21
Q2 2016 -$2.8M -$871K -$249K -40.1% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-01
Q1 2016 -$2.55M -$720K -$98.5K -15.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-04-29
Q4 2015 -$2.46M -$689K -$476K -223% Oct 1, 2015 Dec 31, 2015 10-Q 2017-01-27
Q3 2015 -$1.98M -$523K -$330K -172% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-21
Q2 2015 -$1.65M -$621K -$464K -294% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 -$1.19M -$621K -$451K -265% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 -$734K -$213K -$27.6K -14.8% Oct 1, 2014 Dec 31, 2014 10-Q/A 2017-04-28
Q3 2014 -$706K -$193K Jul 1, 2014 Sep 30, 2014 10-K/A 2017-04-28
Q2 2014 -$158K -$83K -111% Apr 1, 2014 Jun 30, 2014 10-Q/A 2017-04-28
Q1 2014 -$170K -$99.5K -141% Jan 1, 2014 Mar 31, 2014 10-Q/A 2017-04-28
Q4 2013 -$186K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q2 2013 -$74.8K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$70.5K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.